Heatherington continued, “We believe the NIH funded studies will conclude Eclipse offers ease of use, with rapid on/off application, and we expect to get the same or better results with decreased pressure, a reduction in apneas and hypopneas per hour, and improved comfort and compliance over competitive masks.” “Our latest innovation, Eclipse, builds off of the groundbreaking DreamPort® design, which eliminates headgear and addresses many of the issues identified by traditional headgear users.” have obstructive sleep apnea (OSA) and almost half of these people are non-compliant because they do not have a product that fits properly,” said Stuart Heatherington, Bleep executive chairman and DreamPorts creator. The creation of the Board is a requirement following the previously announced $1.7 million SBIR grant that was awarded from the National Institutes of Health (NIH) to Bleep for the development of Eclipse™, the company’s next-generation CPAP solution. (PRWEB) January 12, 2022īleep, LLC, creators of the mask-free DreamPorts™ sleep solution, announced today the appointment of an Institutional Review Board (IRB) to oversee and monitor clinical studies and outcomes for their innovation in Positive Air Pressure (PAP) design for use in home and acute care/hospital settings.
0 kommentar(er)
